This information was published on 2025-06-09T12:54:52 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2551882 (IR 1856482) |
| (220) |
11 Apr 2025
|
| (300) |
US, 16 Oct 2024, 98804636
|
| (500) |
The mark consists of The word "ratio" above the word "therapeutics" with a spiral originating above the "t" and curling to the right of the words with a grid pattern under the spiral.
"therapeutics" |
| (511) (510) |
Class 1
Small molecule chemical structures, namely, reagents for adhering radioactive agents to pharmaceutical compounds for chelating radioisotopes for scientific purposes; chemical agents for chelating radioisotopes. Class 5 Radio-pharmaceutical preparations for the diagnosis and treatment of cancers; radio-pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products in the treatment of cancers; pharmaceutical agents that deliver a range of radioisotopes for therapeutic or diagnostic use. |
| (540) |
|
| (550) | Figurative |
| (730) |
Ratio Therapeutics, Inc.
|
Find out more about publications on the About page.